ALKERMES | ALKS - Interest Income

Stock Price
34.32
Daily Change
-0.64 -1.83%
Monthly
22.57%
Yearly
9.65%
Q1 Forecast
32.88

ALKERMES reported $11.09M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
AbbVie USD 62M 11M Jun/2025
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
ALKERMES USD 11.09M 949K Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Otsuka Holdings JPY 10.49B 396M Jun/2024
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025